Literature DB >> 1829989

Immunological tolerance induced by liver grafting in the rat: splenic macrophages and T cells mediate distinct phases of immunosuppressive activity.

S Yoshimura1, S Gotoh, N Kamada.   

Abstract

In the rat combination DA into PVG, liver grafts are not rejected but induce donor-specific transplantation tolerance. We have examined the immunosuppressive properties of spleen cells from PVG recipients of DA liver grafts at various times post-grafting. The results indicate the development of two phases of cell-mediated suppressor activity, which appear to be mediated by separate spleen cell populations. Mitomycin-C-treated spleen cells taken from animals between 5 and 28 days post-grafting were able to suppress rat mixed lymphocyte reactions (MLRs). These 'early' suppressor cells were glass adherent and absent from populations purified by passage through nylon wool or G10 Sephadex columns. Suppression of MLR by purified glass adherent cells was not specific for either stimulator or responder haplotypes and was blocked by indomethacin. Nylon wool purified T cells were not suppressive at this time. Spleen cell suppressor activity declined to background levels after 35 days post-grafting. However, spleen cells from long-term surviving liver graft recipients (20 weeks or more) were again able to suppress MLR; the 'late' suppressor cells were nylon wool non-adherent and suppression was specific for the donor (DA) MHC type. We conclude that liver grafting in this combination generates early and late phases of suppression among spleen cells, that the early phase is produced by macrophages and mediated by prostaglandins and that the late phase is dependent on allospecific suppressor T cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829989      PMCID: PMC1535718          DOI: 10.1111/j.1365-2249.1991.tb05692.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Control of lymphokine secretion by prostaglandins.

Authors:  D Gordon; M A Bray; J Morley
Journal:  Nature       Date:  1976-07-29       Impact factor: 49.962

Review 2.  The immunology of experimental liver transplantation in the rat.

Authors:  N Kamada
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

3.  Regeneration and the immune system. II. Suppressor activities of lymphocytes activated in vivo by liver regeneration and their genetic control.

Authors:  K Yokomuro; S Miyahara; H Takahashi; Y Kimura
Journal:  Eur J Immunol       Date:  1983-11       Impact factor: 5.532

4.  Regeneration and the immune system. I. In vitro and in vivo activation of lymphocytes by liver regeneration and the role of Kupffer cells in stimulation.

Authors:  S Miyahara; K Yokomuro; H Takahashi; Y Kimura
Journal:  Eur J Immunol       Date:  1983-11       Impact factor: 5.532

5.  Liver transplantation in the rat. Biochemical and histological evidence of complete tolerance induction in non-rejector strains.

Authors:  N Kamada; H S Davies; D Wight; L Culank; B Roser
Journal:  Transplantation       Date:  1983-04       Impact factor: 4.939

6.  Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation.

Authors:  W C Greene; T A Fleisher; T A Waldmann
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

7.  Immunosuppressive activity of serum from liver-grafted rats. Passive enhancement of fully allogeneic heart grafts and induction of systemic tolerance.

Authors:  N Kamada; T Shinomiya; T Tamaki; K Ishiguro
Journal:  Transplantation       Date:  1986-12       Impact factor: 4.939

8.  Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. III. Role of the MLC-stimulating cell population in alpha-fetoprotein-induced suppression of T cell-mediated cytotoxicity.

Authors:  A B Peck; R A Murgita; H Wigzell
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

9.  Suppressor cells and their role in the survival of immunologically enhanced rat kidney allografts.

Authors:  J R Batchelor; B E Phillips; D Grennan
Journal:  Transplantation       Date:  1984-01       Impact factor: 4.939

10.  Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action.

Authors:  B M Hall; N W Pearce; K E Gurley; S E Dorsch
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  7 in total

1.  The fas and fas ligand pathways in liver allograft tolerance.

Authors:  T L Pan; S Goto; Y C Lin; R Lord; K C Chiang; C Y Lai; Y S Chen; H L Eng; Y F Cheng; T Tatsuma; S Kitano; C L Lin; C L Chen
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

2.  The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion.

Authors:  U Dahmen; H Sun; Y Li; F Fu; A J Demetris; T E Starzl; S Qian; J J Fung
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

3.  Induction of T-cell hyporesponsiveness by intrahepatic modulation of donor antigen-presenting cells.

Authors:  S W Chung; R M Gorczynski; I Dziadkowiec; G A Levy
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

4.  Inhibition of rat splenocyte proliferation with methylprednisolone: in vivo effect of liposomal formulation.

Authors:  E V Mishina; W J Jusko
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

Review 5.  The CD8 T-cell response during tolerance induction in liver transplantation.

Authors:  Yik Chun Wong; Geoffrey W McCaughan; David G Bowen; Patrick Bertolino
Journal:  Clin Transl Immunology       Date:  2016-10-14

Review 6.  Monocyte-Derived Suppressor Cells in Transplantation.

Authors:  Jordi Ochando; Patricia Conde; Vincenzo Bronte
Journal:  Curr Transplant Rep       Date:  2015

Review 7.  Induction Phase of Spontaneous Liver Transplant Tolerance.

Authors:  Geoffrey W McCaughan; David G Bowen; Patrick J Bertolino
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.